UPDATE 4-Shah Capital urges Novavax shareholders to vote against three directors [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
to vote against the re-election of three directors and proposals related to executive compensation, weeks after pushing for a board shakeup at the COVID-19 vaccine maker. Shah Capital, the biotech's third-largest shareholder with a near 7.5% stake, reiterated that the company was "undervalued and continues to suffer from poor profitability". Novavax last year had raised doubts about its ability to remain in business, hurt by manufacturing snags and regulatory hurdles that delayed the entry of its protein-based vaccine to the market. Last month, Shah Capital had expressed concerns over mismanagement at the Maryland-based biotech and urged it to adopt a marketing strategy to target consumers who are hesitant to receive mRNA vaccines. Shah Capital had previously said it plans to put forward two of its own candidates for appointment to Novavax's board, but did not formally submit any nominations. Novavax said in a proxy filing last week that it had not received any valid nominat
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers [Yahoo! Finance]Yahoo! Finance
- Up 3x In A Week Will Novavax Stock Continue To See Higher Levels? [Forbes]Forbes
- Could Novavax Become the Next Moderna? [Yahoo! Finance]Yahoo! Finance
- Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY [Yahoo! Finance]Yahoo! Finance
- Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action SettlementAccesswire
NVAX
Earnings
- 2/28/24 - Miss
NVAX
Analyst Actions
- 5/13/24 - HC Wainwright
NVAX
Sec Filings
- 5/15/24 - Form 4
- 5/14/24 - Form 144
- 5/13/24 - Form DFAN14A
- NVAX's page on the SEC website